medigraphic.com
SPANISH

Revista de Endocrinología y Nutrición

ISSN 0188-9796 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2010, Number 3

<< Back

Rev Endocrinol Nutr 2010; 18 (3)

Limitaciones de la GH suprimida por glucosa en la acromegalia activa

Espinosa MAL
Full text How to cite this article

Language: Spanish
References: 10
Page: 159-161
PDF size: 223.72 Kb.


Key words:

No keywords

ABSTRACT




REFERENCES

  1. Giustina A, Barkan A, Casanueva F, Cavagnini F, Frohman L, Ho K et al. Criteria for cure of acromegaly: A Consensus Statement. J Clin Endocrinol Metab 2000; 85: 526-529.

  2. Giustina A, Chanson P, Bronstein M, Klibanski A, Lamberts S, Casanueva F et al. A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 2010; 95: 3141-3148.

  3. Dimaraki E, Jaffe C, DeMott-Friberg R, Chandler W, Barkan A. Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up. J Clin Endocrinol Metab 2002; 87: 3537-3542.

  4. Mercado M, Espinosa de los Monteros AL, Sosa E, Cheng S, Mendoza V, Hernández et al. Clinical-biochemical correlations in acromegaly at diagnosis and the real prevalence of biochemically discordant disease. Horm Res 2004; 62: 293-299.

  5. Cazabat L, Souberbielle J, Chanson Ph. Dynamic tests for the diagnosis and assessment of treatment efficacy in acromegaly. Pituitary 2008; 11: 129-139.

  6. Machado E, Taboada G, Neto L, Haute F, Corrêa L, Balarini G et al. Prevalence of discordant GH and IGF-I levels in acromegalics at diagnosis, after surgical treatment and during treatment with octreotide LAR((R)). Growth Horm IGF Res 2008; 18: 389-393.

  7. Carmichael J, Bonert V, Mirocha J, Melmed SH. The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegaly. J Clin Endocrinol Metab 2009; 94: 523-527.

  8. Espinosa-de-Los-Monteros AL, Sosa E, Cheng S, Ochoa R, Sandoval C, Guinto G et al. Biochemical evaluation of disease activity after pituitary surgery in acromegaly: a critical analysis of patients who spontaneously change disease status. Clinical Endocrinology 2006; 64: 245-249.

  9. Elias P, Lugao H, Pereira M, Machado H, Castro M, Moreira A. Discordant nadir GH after oral glucose and IGF-Ilevels on treated acromegaly: refining the biochemical markers of mild disease activity. Horm Metab Res 2010; 42: 50-55.

  10. Alexopoulou O, Bex M, Abs R, T’Sjoen G, Velkeniers B, Maiter D. Divergence between growth hormone and insulinlike growth factor-1 concentrations in the follow-up of acromegaly. J Clin Endocrinol Metab 2008; 93: 1324-1330.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Endocrinol Nutr. 2010;18